Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CCC Intelligent Soln Holdings Inc | Lauren Young | Director | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 04 Mar 2024 | 30,195,949 | 163,275,807 | - | 11.3 | 342,120,102 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 04 Mar 2024 | 30,195,949 | 163,275,807 | - | 11.3 | 342,120,102 | Common Stock |
| Permian Resources Corp (Class A) | William J. Quinn | Director, Ten Percent Owner | 04 Mar 2024 | 18,076,849 | 18,076,849 (6%) | 6% | - | Class A Common Stock | ||
| Permian Resources Corp (Class A) | William J. Quinn | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.71 per share. | 04 Mar 2024 | 18,076,849 | 71,056,620 (25%) | 6% | 15.7 | 283,987,298 | Class A Common Stock |
| Permian Resources Corp (Class A) | William J. Quinn | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 18,076,849 | 71,056,620 | - | - | Class C Common Stock | |
| Permian Resources Corp (Class A) | William J. Quinn | Director, Ten Percent Owner | 04 Mar 2024 | 18,076,849 | 71,056,620 | - | - | Common Units | ||
| CCC Intelligent Soln Holdings Inc | Lauren Young | Director | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 04 Mar 2024 | 10,014,164 | 54,148,681 | - | 11.3 | 113,460,478 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 04 Mar 2024 | 10,014,164 | 54,148,681 | - | 11.3 | 113,460,478 | Common Stock |
| Portillos Inc Ordinary | Joshua A. Lutzker | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 5,216,808 | 9,037,513 | - | - | LLC Units of PHD Group Holdings LLC | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 67.46 per share. | 04 Mar 2024 | 4,000,000 | 26,321,589 (38%) | 5% | 67.5 | 269,824,000 | Common Stock |
| Portillos Inc Ordinary | Joshua A. Lutzker | Director | Sale or transfer of securities back to the company at price $ 14.37 per share. | 04 Mar 2024 | 2,167,629 | 3,755,165 | - | 14.4 | 31,148,829 | Class A common stock |
| Mawson infra Grp Inc | Rahul Mewawalla | Director, CEO and President | 04 Mar 2024 | 1,587,302 | 1,587,302 | - | - | Restricted Stock Units | ||
| Cava Grp Inc | Ronald M. Shaich | Director, Former 10% Owner | Sale of securities on an exchange or to another person at price $ 57.20 per share. | 04 Mar 2024 | 1,500,000 | 4,457,634 | - | 57.2 | 85,800,000 | Common Stock |
| Mawson infra Grp Inc | Rahul Mewawalla | Director, CEO and President | 04 Mar 2024 | 1,482,226 | 1,482,226 | - | - | Restricted Stock Units | ||
| HUTCHMED (China) Ltd (ADR) | Weiguo Su | Executive Director,Chief Executive Officer | 04 Mar 2024 | 1,403,175 | 6,403,175 (0%) | 0% | 0 | Ords 0.10p | ||
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,333,334 | 1,333,334 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chintu Patel | Director, Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,333,334 | 1,333,334 | - | - | Performance-Based Restricted Stock Units | |
| Starwood Property Trust Inc | Barry S. Sternlicht | Director, CEO, Chairman of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,300,000 | 2,175,000 | - | - | Restricted Stock Units | |
| Arlo Tech Inc | Kurtis J. Binder | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,000,000 | 1,000,000 | - | - | Performance Stock Units (PSUs) | |
| CCC Intelligent Soln Holdings Inc | Lauren Young | Director | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 04 Mar 2024 | 955,026 | 5,164,022 | - | 11.3 | 10,820,445 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Eric Wei | Director | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 04 Mar 2024 | 955,026 | 5,164,022 | - | 11.3 | 10,820,445 | Common Stock |
| Arlo Tech Inc | Matthew McRae | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 866,471 | 866,471 | - | - | Performance Stock Units (PSUs) | |
| Evolv Tech Holdings Inc (Class A) | Peter Gustav George | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 722,021 | 722,021 | - | - | Stock Option (Right to Buy) | |
| Monster Beverage | Mark J. Hall | Director | Sale of securities on an exchange or to another person at price $ 58.55 per share. | 04 Mar 2024 | 659,000 | 777,840 (0%) | 0% | 58.6 | 38,584,450 | Common Stock |
| Bolt Biotherapeutics Inc | Randall C. Schatzman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 654,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Figs Inc (Class A) | Catherine Eva Spear | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 652,174 | 1,187,654 | - | 0 | Class A Common Stock | |
| Therealreal Inc | Chatelle Aileen Lynch | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 650,000 | 650,000 (0%) | 0% | 0 | Common Stock | |
| Progyny Inc | Michael Sturmer | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
| Evolv Tech Holdings Inc (Class A) | Peter Gustav George | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 550,964 | 550,964 | - | - | Restricted Stock Units | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 485,000 | 485,000 | - | - | Stock Option | |
| Portillos Inc Ordinary | Joshua A. Lutzker | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 472,191 | 818,015 | - | - | LLC Units of PHD Group Holdings LLC | |
| Therealreal Inc | Rati Sahi Levesque | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 450,000 | 1,406,616 (1%) | 0% | 0 | Common Stock | |
| MSP Recovery Inc (Class A) | John H. Ruiz | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 04 Mar 2024 | 438,596 | 912,786 | - | 1.1 | 499,999 | LIFW |
| Purple Innovation Inc | Scott Peterson | Director | Other type of transaction at price $ 0.00 per share. | 04 Mar 2024 | 431,355 | 3,179,165 (15%) | 2% | - | Class A Common Stock | |
| American Axle & Manufacturing Holdings Inc | David C. Dauch | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 6.76 per share. | 04 Mar 2024 | 425,296 | 1,452,368 (1%) | 0% | 6.8 | 2,875,001 | Common Stock |
| Clean Energy Fuels Corp | Barclay F. Corbus | SVP, STRATEGIC DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 400,000 | 1,015,208 (0%) | 0% | 0 | Common Stock | |
| TeraWulf Inc | Patrick Fleury | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 400,000 | 0 | - | - | Restricted Stock Units | |
| TeraWulf Inc | Patrick Fleury | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 400,000 | 1,429,824 | - | - | Common stock, $0.001 par value per share | |
| TeraWulf Inc | Kerri M. Langlais | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 400,000 | 1,876,975 | - | - | Common stock, $0.001 par value per share | |
| TeraWulf Inc | Kerri M. Langlais | Director, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 400,000 | 0 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Mark Donohue | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 397,111 | 397,111 | - | - | Stock Option (Right to Buy) | |
| Flywire Corp | Cosmin Pitigoi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 394,128 | 394,128 | - | 0 | Voting Common Stock | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 379,959 | 379,959 | - | - | Stock Option | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 370,370 | 370,370 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chintu Patel | Director, Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 370,370 | 370,370 | - | - | Restricted Stock Units | |
| Adaptive biotech Corp | Chad Robins | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 354,610 | 2,625,374 (2%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 354,610 | 1,021,180 (0%) | 0% | 0 | Common Stock | |
| Evolv Tech Holdings Inc (Class A) | Mark Donohue | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 303,030 | 303,030 | - | - | Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Jay Muelhoefer | Chief Commercial Officer | 04 Mar 2024 | 297,833 | 297,833 | - | - | Stock Option (Right to Buy) | ||
| Therealreal Inc | Todd A. Suko | Chief Legal Officer and Secret | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 280,000 | 883,560 (1%) | 0% | 0 | Common Stock | |
| Immunic Inc | Andreas Muehler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 259,000 | 259,000 | - | - | Stock Option | |
| Clean Energy Fuels Corp | Andrew J. Littlefair | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 250,000 | 1,562,550 (0%) | 0% | 0 | Common Stock | |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 04 Mar 2024 | 250,000 | 250,000 | - | - | Class A Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 04 Mar 2024 | 250,000 | 50,662,136 | - | - | Class B Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.76 per share. | 04 Mar 2024 | 250,000 | 0 | - | 16.8 | 4,190,350 | Class A Common Stock |
| Progyny Inc | Michael Sturmer | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 250,000 | 390,948 (0%) | 0% | 0 | Common Stock | |
| Arlo Tech Inc | Kurtis J. Binder | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 250,000 | 949,038 (1%) | 0% | - | Common Stock | |
| Arlo Tech Inc | Kurtis J. Binder | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 250,000 | 500,000 | - | - | Performance Stock Units (PSUs) | |
| Therealreal Inc | Luke T. Friang | Chief Product and Technology O | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 245,000 | 550,215 (0%) | 0% | 0 | Common Stock | |
| MBIA Inc | William C. Fallon | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 6.47 per share. | 04 Mar 2024 | 243,431 | 3,053,645 (3%) | 0% | 6.5 | 1,574,999 | Common Stock |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.28 per share. | 04 Mar 2024 | 240,490 | 1,597,088 | - | 30.3 | 7,282,759 | Class A Common Stock |
| Crinetics Pharma Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 240,000 | 240,000 | - | - | Stock Option (right to buy) | |
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Edith A. Perez | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Evolv Tech Holdings Inc (Class A) | Jay Muelhoefer | Chief Commercial Officer | 04 Mar 2024 | 227,272 | 227,272 | - | - | Restricted Stock Units | ||
| HUTCHMED (China) Ltd (ADR) | Johnny Cheng Chig Fung | Executive Director,Chief Financial Officer | 04 Mar 2024 | 227,115 | 1,680,095 (0%) | 0% | 0 | Ords 0.10p | ||
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director, Founder & Chief Innovation Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 225,631 | 225,631 | - | - | Stock Option (Right to Buy) | |
| AMMO Inc | Fred W. Wagenhals | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 2.43 per share. | 04 Mar 2024 | 221,138 | 7,066,700 | - | 2.4 | 537,365 | Common Stock |
| Immunic Inc | Glenn Whaley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 220,000 | 220,000 | - | - | Stock Option | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 215,000 | 0 | - | - | Stock Option | |
| Keurig Dr Pepper | Robert J. Gamgort | Director, CEO & Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 211,133 | 0 | - | - | Restricted Stock Unit | |
| Keurig Dr Pepper | Robert J. Gamgort | Director, CEO & Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 211,133 | 3,127,842 (0%) | 0% | 0 | Common Stock | |
| P10 Inc (Class A) | William F. Souder | Director, Chief Operating Officer, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 207,147 | 207,147 | - | - | Stock Options | |
| Airship AI Holdings Inc (Class A) | Louis Lebedin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 200,000 | 200,000 | - | - | Non-Qualified Stock Option (NQSO) | |
| Clean Energy Fuels Corp | Andrew J. Littlefair | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 200,000 | 200,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Therealreal Inc | Steve Lo | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 200,000 | 549,468 (0%) | 0% | 0 | Common Stock | |
| Airship AI Holdings Inc (Class A) | Louis Lebedin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 200,000 | 200,000 | - | - | Non-Qualified Stock Option (NQSO) | |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 199,549 | 199,549 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 199,549 | 199,549 | - | - | Stock Option (right to buy) | |
| Gates Industrial Corp PLC | Ivo Jurek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 191,673 | 191,673 | - | - | Performance-Based Restricted Stock Units | |
| Gates Industrial Corp PLC | Ivo Jurek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 191,673 | 746,369 | - | - | Time-Based Restricted Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Anil R. Chitkara | Founder & Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 180,505 | 180,505 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 175,000 | 511,824 (0%) | 0% | 0 | Common Stock | |
| Clean Energy Fuels Corp | Robert M. Vreeland | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 175,000 | 443,800 (0%) | 0% | 0 | Common Stock | |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director, Founder & Chief Innovation Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 172,176 | 172,176 | - | - | Restricted Stock Units | |
| Keurig Dr Pepper | Robert J. Gamgort | Director, CEO & Executive Chairman | Purchase of securities on an exchange or from another person at price $ 29.10 per share. | 04 Mar 2024 | 171,821 | 3,179,917 (0%) | 0% | 29.1 | 4,999,991 | Common Stock |
| DENTSPLY Sirona Inc | Simon D. Campion | Director, President, CEO & Member of BOD | 04 Mar 2024 | 163,800 | 163,800 | - | - | Stock Option (Right to Buy) | ||
| Keurig Dr Pepper | Robert J. Gamgort | Director, CEO & Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 161,513 | 161,513 | - | - | Restricted Stock Unit | |
| Block Inc (Class A) | Brian Grassadonia | Cash App Lead | 04 Mar 2024 | 153,332 | 0 | - | - | Class B Common Stock | ||
| Block Inc (Class A) | Brian Grassadonia | Cash App Lead | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 153,332 | 153,332 | - | - | Class B Common Stock | |
| Block Inc (Class A) | Brian Grassadonia | Cash App Lead | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 153,332 | 306,668 | - | - | Stock Option (right to buy) | |
| Block Inc (Class A) | Brian Grassadonia | Cash App Lead | 04 Mar 2024 | 153,332 | 555,893 (0%) | 0% | 0 | Class A Common Stock | ||
| Frontier Grp Holdings Inc | Barry L. Biffle | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 151,620 | 1,364,580 | - | - | Stock Option (Right to Buy) | |
| Frontier Grp Holdings Inc | Barry L. Biffle | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.92 per share. | 04 Mar 2024 | 151,620 | 924,601 | - | 3.9 | 594,108 | Common Stock |
| Frontier Grp Holdings Inc | Barry L. Biffle | Director, CEO | Sale of securities on an exchange or to another person at price $ 7.72 per share. | 04 Mar 2024 | 151,620 | 772,981 | - | 7.7 | 1,170,506 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 150,240 | 8,738,160 | - | - | Class B Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 150,240 | 2,253,600 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 150,024 | 150,024 | - | - | Stock Option (right to buy) | |
| Clean Energy Fuels Corp | Robert M. Vreeland | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Clean Energy Fuels Corp | Barclay F. Corbus | SVP, STRATEGIC DEVELOPMENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Acquire) | |
| SoundHound AI Inc (Class A) | Larry Marcus | Director | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 04 Mar 2024 | 150,000 | 383,117 | - | 6.3 | 945,555 | Class A Common Stock |
| Arlo Tech Inc | Brian Busse | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 150,000 | 150,000 | - | - | Performance Stock Units (PSUs) | |
| RxSight Inc | Ron Kurtz | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 149,000 | 149,000 | - | - | Stock Option (right to buy) | |
| Dutch Bros Inc (Class A) | Travis Boersma | Director, Executive Chairman of Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.36 per share. | 04 Mar 2024 | 148,916 | 1,033,604 | - | 30.4 | 4,521,581 | Class A Common Stock |
| Adaptive biotech Corp | Tycho Peterson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 147,790 | 547,009 (0%) | 0% | 0 | Common Stock | |
| Arlo Tech Inc | Matthew McRae | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 145,833 | 291,667 | - | - | Performance Stock Units (PSUs) | |
| Arlo Tech Inc | Matthew McRae | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 145,833 | 2,521,073 (3%) | 0% | - | Common Stock | |
| Portillos Inc Ordinary | Joshua A. Lutzker | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 143,372 | 248,374 | - | - | LLC Units of PHD Group Holdings LLC | |
| SITE Centers Corp | David R. Lukes | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 142,822 | 1,567,194 (0%) | 0% | 0 | Common Shares | |
| Frontier Grp Holdings Inc | Barry L. Biffle | Director, CEO | Sale of securities on an exchange or to another person at price $ 7.38 per share. | 04 Mar 2024 | 142,154 | 772,981 | - | 7.4 | 1,049,097 | Common Stock |
| Ford Motor | Peter C. Stern | President, Integrated Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 138,147 | 138,147 | - | - | Ford Stock Units | |
| Evolv Tech Holdings Inc (Class A) | Anil R. Chitkara | Founder & Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 137,741 | 137,741 | - | - | Restricted Stock Units | |
| Amphastar Pharma Inc | Jack Yongfeng Zhang | Director, CEO & CHIEF SCIENTIFIC OFFICER, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 135,473 | 135,473 | - | - | Employee Stock Option (right to buy) | |
| AdaptHealth Corp | Albert A. Prast | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 135,443 | 0 | - | - | Employee Stock Option (right to buy) | |
| AdaptHealth Corp | Albert A. Prast | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 04 Mar 2024 | 135,443 | 316,526 (0%) | 0% | 2.7 | 364,342 | Common Stock |
| AdaptHealth Corp | Albert A. Prast | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 04 Mar 2024 | 135,443 | 181,083 (0%) | 0% | 10.4 | 1,409,962 | Common Stock |
| TripAdvisor Inc | Matt Goldberg | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 133,185 | 133,185 | - | - | Restricted Stock Units (Performance-Based) | |
| TripAdvisor Inc | Matt Goldberg | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 133,185 | 133,185 | - | - | Restricted Stock Units | |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 132,979 | 356,805 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 132,979 | 261,281 (0%) | 0% | 0 | Common Stock | |
| Arlo Tech Inc | Matthew McRae | Director, CEO | Sale of securities on an exchange or to another person at price $ 10.95 per share. | 04 Mar 2024 | 132,214 | 2,314,950 (3%) | 0% | 11.0 | 1,447,796 | Common Stock |
| Hayward Holdings Inc | P. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 130,650 | 522,799 | - | 0 | Common Stock | |
| Arlo Tech Inc | Kurtis J. Binder | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.40 per share. | 04 Mar 2024 | 129,200 | 819,838 (1%) | 0% | 11.4 | 1,472,880 | Common Stock |
| SEACOR Marine Holdings Inc | Jesus Llorca | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 128,328 | 504,625 (2%) | 0% | 0 | Common Stock | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 126,000 | 126,000 | - | - | Stock Option (right to buy) | |
| P10 Inc (Class A) | William F. Souder | Director, Chief Operating Officer, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 125,157 | 125,157 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 124,437 | 124,437 | - | - | Restricted Stock Units | |
| Keurig Dr Pepper | Timothy P. Cofer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 120,275 | 120,275 | - | - | Restricted Stock Unit | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 120,000 | 0 | - | - | Stock Option | |
| Monster Beverage | Mark J. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 120,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Monster Beverage | Mark J. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 120,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Monster Beverage | Mark J. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.58 per share. | 04 Mar 2024 | 120,000 | 1,147,840 (0%) | 0% | 22.6 | 2,709,600 | Common Stock |
| Monster Beverage | Mark J. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.82 per share. | 04 Mar 2024 | 120,000 | 1,267,840 (0%) | 0% | 21.8 | 2,618,400 | Common Stock |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Other type of transaction at price $ 2.50 per share. | 04 Mar 2024 | 120,000 | 1,255,219 (5%) | 0% | 2.5 | 300,000 | Common Stock |
| Schrodinger Inc | Karen Akinsanya | President of R&D, Therapeutics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Arlo Tech Inc | Matthew McRae | Director, CEO | Sale of securities on an exchange or to another person at price $ 10.91 per share. | 04 Mar 2024 | 119,900 | 2,195,050 (2%) | 0% | 10.9 | 1,308,133 | Common Stock |
| Keurig Dr Pepper | Robert J. Gamgort | Director, CEO & Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.10 per share. | 04 Mar 2024 | 119,746 | 3,008,096 (0%) | 0% | 29.1 | 3,484,609 | Common Stock |
| Mawson infra Grp Inc | Ryan Costello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 118,395 | 118,395 | - | - | Restricted Stock Units | |
| Fortive | James A. Lico | Director, President and CEO | 04 Mar 2024 | 117,030 | 117,030 | - | - | Employee Stock Option (Right to Buy) | ||
| East West Bancorp Inc | Dominic Ng | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 116,164 | 1,011,492 (0%) | 0% | 0 | Common Stock | |
| MBIA Inc | Adam T. Bergonzi | Assistant Vice President | Grant, award, or other acquisition of securities at price $ 6.47 per share. | 04 Mar 2024 | 115,920 | 1,029,705 (1%) | 0% | 6.5 | 750,002 | Common Stock |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 115,000 | 0 | - | - | Stock Option | |
| Block Inc (Class A) | Brian Grassadonia | Cash App Lead | Sale of securities on an exchange or to another person at price $ 78.17 per share. | 04 Mar 2024 | 111,914 | 443,979 (0%) | 0% | 78.2 | 8,748,317 | Class A Common Stock |
| Iron Mountain | William L. Meaney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 78.80 per share. | 04 Mar 2024 | 110,794 | 300,834 (0%) | 0% | 78.8 | 8,730,900 | Common Stock, par value $.01 per share |
| Public Storage | Ronald L. Havner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 103,275 | 103,275 | - | - | AO LTIP Units | |
| Public Storage | Ronald L. Havner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 103,275 | 103,275 | - | - | AO LTIP Units | |
| Public Storage | Ronald L. Havner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 103,275 | 0 | - | - | Stock Option (Right to Buy) | |
| Public Storage | Ronald L. Havner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 103,275 | 103,275 | - | - | AO LTIP Units | |
| Public Storage | Ronald L. Havner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 103,275 | 0 | - | - | Stock Option (Right to Buy) | |
| Public Storage | Ronald L. Havner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 103,275 | 103,275 | - | - | AO LTIP Units | |
| Public Storage | Ronald L. Havner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 103,275 | 0 | - | - | Stock Option (Right to Buy) | |
| Public Storage | Ronald L. Havner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 103,275 | 0 | - | - | Stock Option (Right to Buy) | |
| Keurig Dr Pepper | Sudhanshu Shekhar Priyadarshi | CFO, President International | 04 Mar 2024 | 103,093 | 103,093 | - | - | Restricted Stock Unit | ||
| Sotera Health Co | Alexander Dimitrief | SVP, General Counsel and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 102,095 | 102,095 | - | - | Stock Options | |
| Compass Inc (Class A) | Kalani Reelitz | Chief Financial Officer | 04 Mar 2024 | 100,000 | 1,100,000 | - | - | Restricted Stock Unit (RSU) | ||
| Compass Inc (Class A) | Kalani Reelitz | Chief Financial Officer | 04 Mar 2024 | 100,000 | 426,480 | - | 0 | Class A Common Stock | ||
| Immunic Inc | Andreas Muehler | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 100,000 | 0 | - | - | Stock Option | |
| Linde | Stephen F. Angel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 100,000 | 335,850 | - | - | Stock Option (right to buy) | |
| Linde | Stephen F. Angel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.71 per share. | 04 Mar 2024 | 100,000 | 474,456 (0%) | 0% | 118.7 | 11,871,000 | Ordinary Shares |
| Monster Beverage | Mark J. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 100,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Monster Beverage | Mark J. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.37 per share. | 04 Mar 2024 | 100,000 | 1,367,840 (0%) | 0% | 29.4 | 2,937,000 | Common Stock |
| Madison Square Garden Entertainment Corp (Class A) | James L. Dolan | Director, Executive Chairman / CEO, Member of 13(d) Group | Sale of securities on an exchange or to another person at price $ 38.20 per share. | 04 Mar 2024 | 100,000 | 192,143 | - | 38.2 | 3,819,790 | Class A Common Stock |
| Sunshine Biopharma Inc | Steve Slilaty | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.10 per share. | 04 Mar 2024 | 100,000 | 130,000 | - | 0.1 | 10,000 | Series B Preferred Stock |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 99,976 | 268,445 (0%) | 0% | 0 | Common Stock | |
| American Axle & Manufacturing Holdings Inc | Michael Joseph Lynch | President & COO | Grant, award, or other acquisition of securities at price $ 6.76 per share. | 04 Mar 2024 | 99,853 | 397,969 (0%) | 0% | 6.8 | 675,006 | Common Stock |
| American Axle & Manufacturing Holdings Inc | Christopher J. May | EVP & CFO | Grant, award, or other acquisition of securities at price $ 6.76 per share. | 04 Mar 2024 | 99,853 | 597,401 (0%) | 0% | 6.8 | 675,006 | Common Stock |
| Arlo Tech Inc | Kurtis J. Binder | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.93 per share. | 04 Mar 2024 | 99,038 | 720,800 (0%) | 0% | 10.9 | 1,082,753 | Common Stock |
| Mosaic | Bruce M. Bodine | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 96,031 | 96,031 | - | - | Restricted Stock Units | |
| Crinetics Pharma Inc | Marc J.S. Wilson | CFO | 04 Mar 2024 | 95,500 | 95,500 | - | - | Stock Option (right to buy) | ||
| Darling Ingredients Inc | Randall C. Stuewe | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 94,862 | 771,333 (0%) | 0% | 0 | Common Stock | |
| Verra Mobility Corp (Class A) | David Roberts | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 93,867 | 691,989 (0%) | 0% | 0 | Class A Common Stock | |
| Coinbase Global Inc (Class A) | Lawrence J. Brock | Chief People Officer | Sale of securities on an exchange or to another person at price $ 225.19 per share. | 04 Mar 2024 | 93,475 | 24,834 | - | 225.2 | 21,050,065 | Class A Common Stock |
| Viatris | Theodora Mistras | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 93,447 | 93,447 | - | - | Restricted Stock Units | |
| ACI Worldwide Inc | Thomas W. Warsop | Director, Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 93,143 | 272,183 (0%) | 0% | 0 | Common Stock | |
| RxSight Inc | Eric Weinberg | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 92,200 | 92,200 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 92,200 | 92,200 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Ilya Goldshleger | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 92,200 | 92,200 | - | - | Stock Option (right to buy) | |
| Keurig Dr Pepper | Robert J. Gamgort | Director, CEO & Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 92,097 | 61,398 | - | - | Restricted Stock Unit | |
| Keurig Dr Pepper | Robert J. Gamgort | Director, CEO & Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 92,097 | 2,916,709 (0%) | 0% | 0 | Common Stock | |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 90,000 | 0 | - | - | Stock Option | |
| Schrodinger Inc | Geoffrey Craig Porges | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Coty Inc (Class A) | Robert S. Singer | Director | Sale of securities on an exchange or to another person at price $ 12.56 per share. | 04 Mar 2024 | 90,000 | 169,982 (0%) | 0% | 12.6 | 1,130,058 | Class A common stock |
| Pfizer | Albert Bourla | Director, Chairman & CEO | 04 Mar 2024 | 88,240 | 659,573 | - | - | Phantom Stock Units SSP | ||
| American Public Education Inc | Angela K. Selden | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 88,056 | 450,851 (2%) | 0% | 0 | Common Stock, par value $.01 | |
| Schrodinger Inc | Ramy Farid | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 87,271 | 87,271 | - | - | Stock Option (right to buy) | |
| Crinetics Pharma Inc | Stephen F. Betz | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 87,000 | 87,000 | - | - | Stock Option (right to buy) | |
| Crinetics Pharma Inc | Dana Pizzuti | Chief Med and Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 87,000 | 87,000 | - | - | Stock Option (right to buy) | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 87,000 | 87,000 | - | - | Stock Option (right to buy) | |
| Keurig Dr Pepper | Sudhanshu Shekhar Priyadarshi | CFO, President International | 04 Mar 2024 | 85,911 | 85,911 | - | - | Restricted Stock Unit | ||
| Keurig Dr Pepper | Sudhanshu Shekhar Priyadarshi | CFO, President International | 04 Mar 2024 | 85,910 | 218,566 (0%) | 0% | 29.1 | 2,499,981 | Common Stock | |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | 04 Mar 2024 | 85,637 | 8,652,523 | - | - | Class B Common Stock | ||
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | 04 Mar 2024 | 85,637 | 422,884 (0%) | 0% | 0.3 | 26,265 | Class A Common Stock | |
| IonQ Inc | Thomas G. Kramer | CHIEF FINANCIAL OFFICER | 04 Mar 2024 | 85,285 | 973,896 | - | 0 | Common Stock | ||
| Linde | Matthew J. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 102.22 per share. | 04 Mar 2024 | 85,205 | 142,839 (0%) | 0% | 102.2 | 8,709,655 | Ordinary Shares |
| Linde | Matthew J. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 85,205 | 0 | - | - | Stock Option (right to buy) | |
| B. Riley Fin Inc | Bryant R. Riley | Director, Chairman and Co-CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 83,086 | 6,861,859 (25%) | 0% | 0 | Common Stock | |
| B. Riley Fin Inc | Thomas J. Kelleher | Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 83,086 | 178,502 (0%) | 0% | 0 | Common Stock | |
| Teva- pharma Ind Ltd (ADR) | Christine Fox | EVP, Head of U.S. Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 81,845 | 81,845 | - | - | Restricted Share Units | |
| Sotera Health Co | Jonathan M. Lyons | Sr. Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 81,676 | 81,676 | - | - | Stock Options | |
| Lantheus Holdings Inc | Mary Anne Heino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 81,169 | 345,506 (0%) | 0% | 0 | Common Stock | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 80,000 | 0 | - | - | Stock Option | |
| TeraWulf Inc | Kenneth Deane | Chief Acct Officer + Treasurer | 04 Mar 2024 | 80,000 | 320,636 | - | - | Common stock, $0.001 par value per share | ||
| TeraWulf Inc | Kenneth Deane | Chief Acct Officer + Treasurer | 04 Mar 2024 | 80,000 | 0 | - | - | Restricted Stock Units | ||
| American Axle & Manufacturing Holdings Inc | Tolga I. Tolga | President Driveline | Grant, award, or other acquisition of securities at price $ 6.76 per share. | 04 Mar 2024 | 79,882 | 141,246 (0%) | 0% | 6.8 | 540,002 | Common Stock |
| Coinbase Global Inc (Class A) | Lawrence J. Brock | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.71 per share. | 04 Mar 2024 | 78,762 | 118,309 | - | 18.7 | 1,473,637 | Class A Common Stock |
| Coinbase Global Inc (Class A) | Lawrence J. Brock | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 78,762 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cactus Inc (Class A) | Scott Bender | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 45.79 per share. | 04 Mar 2024 | 78,000 | 20 (0%) | 0% | 45.8 | 3,571,620 | Class A Common Stock |
| Holley Inc (Class A) | Jesse Weaver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 4.22 per share. | 04 Mar 2024 | 77,310 | 292,588 | - | 4.2 | 326,248 | Common Stock |
| P10 Inc (Class A) | Amanda Coussens | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 76,972 | 76,972 | - | - | Restricted Stock Units | |
| SEACOR Marine Holdings Inc | Jesus Llorca | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. | 04 Mar 2024 | 76,564 | 428,061 (1%) | 0% | 12.3 | 940,206 | Common Stock |
| Sphere Entertainment Co (Class A) | James L. Dolan | Director, Executive Chairman / CEO, Member of 13(d) Group | Purchase of securities on an exchange or from another person at price $ 47.19 per share. | 04 Mar 2024 | 76,079 | 628,944 | - | 47.2 | 3,590,229 | Class A Common Stock |
| MBIA Inc | Christopher H. Young | Assistant Vice President | Grant, award, or other acquisition of securities at price $ 6.47 per share. | 04 Mar 2024 | 75,348 | 692,518 (0%) | 0% | 6.5 | 487,502 | Common Stock |
| MBIA Inc | Daniel M. Avitabile | Assistant Vice President | Grant, award, or other acquisition of securities at price $ 6.47 per share. | 04 Mar 2024 | 75,348 | 692,249 (0%) | 0% | 6.5 | 487,502 | Common Stock |
| Immunic Inc | Duane D. Nash | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 75,000 | 0 | - | - | Stock Option | |
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 75,000 | 75,000 | - | - | Restricted Stock Unit | |
| Service Corp Intl | Thomas L. Ryan | Director, President, CEO & Chairman | Sale of securities on an exchange or to another person at price $ 73.53 per share. | 04 Mar 2024 | 75,000 | 988,365 (0%) | 0% | 73.5 | 5,514,713 | Common Stock |
| Service Corp Intl | Thomas L. Ryan | Director, President, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.25 per share. | 04 Mar 2024 | 75,000 | 1,063,365 (0%) | 0% | 29.3 | 2,193,750 | Common Stock |
| Service Corp Intl | Thomas L. Ryan | Director, President, CEO & Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 75,000 | 247,000 | - | - | Employee Stock Option (right to buy) | |
| Donnelley Fin Soln Inc | Daniel N. Leib | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 65.53 per share. | 04 Mar 2024 | 74,530 | 571,640 (1%) | 0% | 65.5 | 4,883,951 | Common Stock |
| Arlo Tech Inc | Matthew McRae | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.40 per share. | 04 Mar 2024 | 73,909 | 2,447,164 (3%) | 0% | 11.4 | 842,563 | Common Stock |
| SITE Centers Corp | David R. Lukes | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.64 per share. | 04 Mar 2024 | 72,911 | 1,494,283 (0%) | 0% | 13.6 | 994,506 | Common Shares |
| Iron Mountain | William L. Meaney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 78.70 per share. | 04 Mar 2024 | 72,273 | 476,388 (0%) | 0% | 78.7 | 5,687,813 | Common Stock, par value $.01 per share |
| Immunic Inc | Glenn Whaley | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 70,000 | 0 | - | - | Stock Option | |
| Hewlett Packard | Gary M. Reiner | Director | Sale of securities on an exchange or to another person at price $ 17.22 per share. | 04 Mar 2024 | 70,000 | 181,686 (0%) | 0% | 17.2 | 1,205,400 | Common Stock |
| American Axle & Manufacturing Holdings Inc | Terri M. Kemp | SVP - HR & Sustainability | Grant, award, or other acquisition of securities at price $ 6.76 per share. | 04 Mar 2024 | 69,897 | 287,179 (0%) | 0% | 6.8 | 472,504 | Common Stock |
| American Axle & Manufacturing Holdings Inc | Matthew K. Paroly | VP & General Counsel | Grant, award, or other acquisition of securities at price $ 6.76 per share. | 04 Mar 2024 | 69,897 | 154,838 (0%) | 0% | 6.8 | 472,504 | Common Stock |
| Donnelley Fin Soln Inc | Daniel N. Leib | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.53 per share. | 04 Mar 2024 | 69,888 | 501,752 (1%) | 0% | 65.5 | 4,579,761 | Common Stock |
| Five9 Inc | Michael Burkland | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 69,343 | 315,171 (0%) | 0% | 0 | Common Stock | |
| United States Cellular Corp | Laurent C. Therivel | Director, President and CEO | 04 Mar 2024 | 68,751 | 68,751 | - | - | Restricted Stock Units | ||
| Global Net Lease Inc | Edward M. Weil | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 67,385 | 259,939 (0%) | 0% | 0 | Common Stock | |
| Teva- pharma Ind Ltd (ADR) | David R. McAvoy | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 66,964 | 66,964 | - | - | Restricted Share Units | |
| Farmland Partners Inc | Paul A. Pittman | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 66,943 | 1,365,448 (4%) | 0% | 0 | Common Stock | |
| SEACOR Marine Holdings Inc | Andrew H. Everett | Sr. VP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 66,378 | 262,556 (1%) | 0% | 0 | Common Stock | |
| Crinetics Pharma Inc | R. Scott Struthers | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 65,000 | 250,522 (1%) | 0% | 0 | Common Stock | |
| Immunic Inc | Daniel Vitt | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 65,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Andreas Muehler | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 65,000 | 0 | - | - | Stock Option | |
| Universal Health Services (Class B) | Alan B. Miller | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 134.02 per share. | 04 Mar 2024 | 65,000 | 1,155,452 (1%) | 0% | 134.0 | 8,711,300 | Class B Common Stock |
| Universal Health Services (Class B) | Alan B. Miller | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 65,000 | 130,000 | - | - | Option To Purchase Class B Common Stock | |
| Immunic Inc | Barclay A. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 64,959 | 64,959 | - | - | Stock Option | |
| Immunic Inc | Joerg Neermann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 64,959 | 64,959 | - | - | Stock Option | |
| Enovis Corp | Matthew L. Trerotola | Director, CEO | 04 Mar 2024 | 64,484 | 276,231 (0%) | 0% | 0 | Common stock, par value $0.001 | ||
| Amphastar Pharma Inc | Jack Yongfeng Zhang | Director, CEO & CHIEF SCIENTIFIC OFFICER, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 64,310 | 2,143,028 (4%) | 0% | 0 | Common Stock | |
| Tigo Energy Inc | Bill Roeschlein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 63,883 | 139,970 | - | 0 | Common Stock | |
| P10 Inc (Class A) | Nell M. Blatherwick | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 63,330 | 63,330 | - | - | Restricted Stock Unit | |
| P10 Inc (Class A) | Nell M. Blatherwick | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 63,330 | 63,330 | - | - | Restricted Stock Unit | |
| Taylor Morrison Home Corp | William H. Lyon | Director | Sale of securities on an exchange or to another person at price $ 58.30 per share. | 04 Mar 2024 | 63,210 | 2,664,106 (1%) | 0% | 58.3 | 3,685,143 | Common Stock |
| Crinetics Pharma Inc | James Hassard | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 63,000 | 63,000 | - | - | Stock Option (right to buy) | |
| DENTSPLY Sirona Inc | Glenn G. Coleman | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 62,800 | 62,800 | - | - | Stock Option (Right to Buy) | |
| Vita Coco Co Inc | Martin F. Roper | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 62,743 | 62,743 | - | - | Non-Qualified Stock Option (right to buy) | |
| Vita Coco Co Inc | Michael Kirban | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 62,743 | 62,743 | - | - | Non-Qualified Stock Option (right to buy) | |
| IonQ Inc | Rima Alameddine | CHIEF REVENUE OFFICER | 04 Mar 2024 | 62,025 | 724,859 | - | 0 | Common Stock | ||
| SEACOR Marine Holdings Inc | Gregory S. Rossmiller | SVP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 61,953 | 251,390 (1%) | 0% | 0 | Common Stock | |
| Darling Ingredients Inc | Randall C. Stuewe | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.94 per share. | 04 Mar 2024 | 61,124 | 795,128 (0%) | 0% | 19.9 | 1,218,813 | Common Stock |
| Darling Ingredients Inc | Randall C. Stuewe | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 61,124 | 0 | - | - | Options (right to buy) | |
| Akamai Tech | F. Thomson Leighton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 60,942 | 60,942 | - | - | Restricted Stock Units | |
| Linde | Stephen F. Angel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 453.50 per share. | 04 Mar 2024 | 60,410 | 414,046 (0%) | 0% | 453.5 | 27,395,935 | Ordinary Shares |
| TripAdvisor Inc | Michael Noonan | CFO & SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 60,118 | 60,118 | - | - | Restricted Stock Units | |
| TripAdvisor Inc | Michael Noonan | CFO & SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 60,118 | 60,118 | - | - | Restricted Stock Units (Performance-Based) | |
| Adaptive biotech Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2024 | 60,010 | 60,010 | - | - | Stock Option (right to buy) | ||
| Schrodinger Inc | Robert Abel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Yvonne Tran | EVP, CLO & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Schrodinger Inc | Margaret Dugan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Lantheus Holdings Inc | Mary Anne Heino | Director | Sale of securities on an exchange or to another person at price $ 65.59 per share. | 04 Mar 2024 | 59,251 | 251,743 (0%) | 0% | 65.6 | 3,886,516 | Common Stock |
| Holley Inc (Class A) | Carly Kennedy | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 4.22 per share. | 04 Mar 2024 | 58,294 | 218,473 | - | 4.2 | 246,001 | Common Stock |
| Cingulate Inc | Shane J. Schaffer | Director, Chief Executive Officer | 04 Mar 2024 | 57,323 | 57,323 | - | - | Stock Option (right to Buy) | ||
| Amphastar Pharma Inc | Jack Yongfeng Zhang | Director, CEO & CHIEF SCIENTIFIC OFFICER, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 57,109 | 57,109 | - | - | Employee Stock Option (right to buy) | |
| DENTSPLY Sirona Inc | Andreas G. Frank | Executive VP, Product Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 56,500 | 56,500 | - | - | Stock Option (Right to Buy) | |
| Universal Health Services (Class B) | Alan B. Miller | Director, Executive Chairman, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 174.60 per share. | 04 Mar 2024 | 56,311 | 1,099,141 (1%) | 0% | 174.6 | 9,831,901 | Class B Common Stock |
| Perella Weinberg Partners | Peter A. Weinberg | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.54 per share. | 04 Mar 2024 | 56,048 | 1,987,069 | - | 13.5 | 758,890 | Class A Common Stock |
| East West Bancorp Inc | Dominic Ng | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.22 per share. | 04 Mar 2024 | 55,551 | 955,941 (0%) | 0% | 73.2 | 4,067,444 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 55,243 | 55,243 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Tobin W. Juvenal | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 55,243 | 55,243 | - | - | Restricted Stock Units | |
| Global Net Lease Inc | Christopher J. Masterson | CFO, Secretary and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 55,148 | 224,353 (0%) | 0% | 0 | Common Stock | |
| Flux Power Holdings inc | Kevin S. Royal | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 55,000 | 55,000 | - | - | Stock Options (right to buy) | |
| Ingredion Inc | James P. Zallie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 117.24 per share. | 04 Mar 2024 | 54,581 | 99,245 (0%) | 0% | 117.2 | 6,399,295 | Common Stock |
| Inhibrx Inc | Kelly D. Deck | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 53,958 | 16,042 | - | - | Stock Option (right to buy) | |
| Sempra Energy | Jeffrey Walker Martin | Director, Chairman, CEO and President | 04 Mar 2024 | 53,289 | 146,170 | - | - | Phantom Shares | ||
| Packaging Corp of America | Mark W. Kowlzan | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 186.70 per share. | 04 Mar 2024 | 53,196 | 474,010 (0%) | 0% | 186.7 | 9,931,693 | Common Stock |
| Sempra Energy | Jeffrey Walker Martin | Director, Chairman, CEO and President | 04 Mar 2024 | 52,873 | 145,754 | - | - | Phantom Shares | ||
| ITT Inc | Luca Savi | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 52,488 | 252,116 (0%) | 0% | 0 | Common Stock | |
| Teva- pharma Ind Ltd (ADR) | Angus Grant | EVP, Business Development | 04 Mar 2024 | 52,083 | 52,083 | - | - | Restricted Share Units | ||
| Keurig Dr Pepper | Matthew Andrew Archambault | President, US Refreshment Bev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 51,547 | 51,547 | - | - | Restricted Stock Unit | |
| Sotera Health Co | Alexander Dimitrief | SVP, General Counsel and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 51,405 | 286,883 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Linde | Matthew J. White | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 455.84 per share. | 04 Mar 2024 | 51,231 | 57,634 (0%) | 0% | 455.8 | 23,353,139 | Ordinary Shares |
| Hayward Holdings Inc | Eifion Jones | Senior Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 50,848 | 258,903 | - | 0 | Common Stock | |
| SEACOR Marine Holdings Inc | Jesus Llorca | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 50,475 | 50,475 | - | - | Performance Restricted Stock Units | |
| F&G Annuities & Life Inc | William P. Foley | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.78 per share. | 04 Mar 2024 | 50,411 | 859,910 | - | 37.8 | 1,904,528 | Common Stock |
| LanzaTech Global Inc (Class A) | Freya Burton | Chief Sustainability Officer | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 04 Mar 2024 | 50,225 | 0 | - | 3.2 | 162,729 | Common Stock |
| LanzaTech Global Inc (Class A) | Freya Burton | Chief Sustainability Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.60 per share. | 04 Mar 2024 | 50,225 | 50,225 | - | 1.6 | 80,360 | Common Stock |
| Amazon | Andrew R. Jassy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 180.00 per share. | 04 Mar 2024 | 50,000 | 1,994,182 (0%) | 0% | 180 | 9,000,000 | Common Stock, par value $.01 per share |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 402.70 per share. | 04 Mar 2024 | 50,000 | 4,933,019 (13%) | 0% | 402.7 | 20,135,000 | Common Stock |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 403.12 per share. | 04 Mar 2024 | 50,000 | 4,983,019 (13%) | 0% | 403.1 | 20,156,000 | Common Stock |
| Pennant Group Inc | Brent Guerisoli | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Toll Brothers Inc | Douglas C. Yearley | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.85 per share. | 04 Mar 2024 | 50,000 | 396,382 (0%) | 0% | 32.9 | 1,642,500 | Common Stock |
| Toll Brothers Inc | Douglas C. Yearley | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 50,000 | 87,584 | - | - | Stock Options (Right to Buy) | |
| Atkore Inc | William E. Waltz | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 173.85 per share. | 04 Mar 2024 | 50,000 | 83,716 (0%) | 0% | 173.8 | 8,692,350 | Common Stock |
| P10 Inc (Class A) | Mark C. Hood | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 50,000 | 50,000 | - | - | Employee stock option (right to buy) | |
| Chefs` Warehouse Inc | Christopher Pappas | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 49,842 | 2,406,312 (7%) | 0% | - | Common Stock | |
| Linde | Matthew J. White | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 456.35 per share. | 04 Mar 2024 | 49,726 | 93,113 (0%) | 0% | 456.3 | 22,692,460 | Ordinary Shares |
| Gates Industrial Corp PLC | L. Brooks Mallard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 49,655 | 49,655 | - | - | Performance-Based Restricted Stock Units | |
| Gates Industrial Corp PLC | L. Brooks Mallard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 49,655 | 173,604 | - | - | Time-Based Restricted Stock Units | |
| Acadia Realty Trust | Joseph M. Napolitano | Sr. VP | Sale of securities on an exchange or to another person at price $ 16.77 per share. | 04 Mar 2024 | 49,525 | 118 (0%) | 0% | 16.8 | 830,609 | Common Shares of Beneficial Interest - $.001 Par Value |
| Acadia Realty Trust | Joseph M. Napolitano | Sr. VP | 04 Mar 2024 | 49,525 | 179,108 | - | - | Limited Partnership Units | ||
| Acadia Realty Trust | Joseph M. Napolitano | Sr. VP | 04 Mar 2024 | 49,525 | 49,643 (0%) | 0% | 0 | Common Shares of Beneficial Interest - $.001 Par Value | ||
| Fortive | Olumide Soroye | President & CEO of IOS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 49,510 | 49,510 | - | - | Employee Stock Option (Right to Buy) | |
| DENTSPLY Sirona Inc | Simon D. Campion | Director, President, CEO & Member of BOD | 04 Mar 2024 | 48,978 | 290,374 (0%) | 0% | 0 | Common Stock | ||
| T-Mobile US | G. Michael Sievert | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,821 | 497,336 (0%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | Frank Stokes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,744 | 48,744 | - | - | Restricted Stock Units | |
| Adaptive biotech Corp | Michael J. Pellini | Director | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | ||
| Adaptive biotech Corp | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Robert M. Hershberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Einterz Owen Katey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Perella Weinberg Partners | Andrew Bednar | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.54 per share. | 04 Mar 2024 | 47,967 | 495,929 | - | 13.5 | 649,473 | Class A Common Stock |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | 04 Mar 2024 | 47,365 | 4,392,653 | - | - | Class B Common Stock | ||
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 47,365 | 4,440,018 | - | - | Class B Common Stock | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 47,365 | 585,811 | - | - | Stock Option (right to buy) | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | 04 Mar 2024 | 47,365 | 4,392,653 | - | - | Class B Common Stock | ||
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 47,365 | 4,440,018 | - | - | Class B Common Stock | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 47,365 | 633,176 | - | - | Stock Option (right to buy) | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | 04 Mar 2024 | 47,365 | 1,354,549 | - | 2.3 | 107,519 | Class A Common Stock | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | 04 Mar 2024 | 47,365 | 1,354,549 | - | 2.3 | 107,519 | Class A Common Stock | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 27.39 per share. | 04 Mar 2024 | 47,165 | 1,307,384 | - | 27.4 | 1,291,981 | Class A Common Stock |
| SLR Investment Corp | Michael S. Gross | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 15.23 per share. | 04 Mar 2024 | 46,700 | 3,688,824 (8%) | 0% | 15.2 | 711,241 | Common Stock |
| SLR Investment Corp | Bruce J. Spohler | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 15.23 per share. | 04 Mar 2024 | 46,700 | 3,527,100 (8%) | 0% | 15.2 | 711,241 | Common Stock |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 04 Mar 2024 | 45,965 | 1,308,584 | - | 25.4 | 1,168,614 | Class A Common Stock |
| Toll Brothers Inc | Douglas C. Yearley | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 118.81 per share. | 04 Mar 2024 | 45,701 | 350,681 (0%) | 0% | 118.8 | 5,429,626 | Common Stock |
| Compass Inc (Class A) | Kalani Reelitz | Chief Financial Officer | 04 Mar 2024 | 45,502 | 380,978 | - | 3.7 | 168,812 | Class A Common Stock | |
| TriNet Grp Inc | Burton M. Goldfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 45,455 | 136,420 (0%) | 0% | 0 | Common Stock | |
| Trimble | Robert G. Painter | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2024 | 45,346 | 45,346 (0%) | 0% | 0 | Common Stock | |
| Trimble | Robert G. Painter | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2024 | 45,346 | 190,555 (0%) | 0% | 0 | Common Stock | |
| Howmet Aerospace | Neil E. Marchuk | EVP, HR | Sale of securities on an exchange or to another person at price $ 67.44 per share. | 04 Mar 2024 | 45,000 | 229,568 (0%) | 0% | 67.4 | 3,034,872 | Common Stock |
| Progyny Inc | Mark Livingston | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Progyny Inc | Allison Swartz | EVP, GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| B. Riley Fin Inc | Andrew Moore | CEO B. Riley Securities, Inc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 44,510 | 362,565 (1%) | 0% | 0 | Common Stock | |
| Perella Weinberg Partners | Dietrich Becker | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.54 per share. | 04 Mar 2024 | 44,044 | 420,293 | - | 13.5 | 596,356 | Class A Common Stock |
| Immunic Inc | Andreas Muehler | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 44,000 | 0 | - | - | Stock Option | |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.57 per share. | 04 Mar 2024 | 43,876 | 146,674 | - | 13.6 | 595,498 | Class A Common Stock |
| Adaptive biotech Corp | Kyle Piskel | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 43,740 | 131,045 (0%) | 0% | 0 | Common Stock | |
| Fulcrum Therapeutics Inc | Alex C. Sapir | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 11.35 per share. | 04 Mar 2024 | 43,360 | 43,360 (0%) | 0% | 11.3 | 492,028 | Common Stock |
| Adaptive biotech Corp | Chad Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 42,794 | 2,576,701 (2%) | 0% | 3.4 | 146,783 | Common Stock |
| Fortive | Charles E. McLaughlin | SVP - Chief Financial Officer | 04 Mar 2024 | 42,760 | 42,760 | - | - | Employee Stock Option (Right to Buy) | ||
| Donnelley Fin Soln Inc | Daniel N. Leib | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 42,292 | 544,044 (1%) | 0% | - | Common Stock | |
| Iron Mountain | William L. Meaney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 79.21 per share. | 04 Mar 2024 | 42,206 | 434,182 (0%) | 0% | 79.2 | 3,343,095 | Common Stock, par value $.01 per share |
| Arlo Tech Inc | Brian Busse | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 10.97 per share. | 04 Mar 2024 | 42,161 | 661,878 (0%) | 0% | 11.0 | 462,371 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 128.58 per share. | 04 Mar 2024 | 42,073 | 337,254 (0%) | 0% | 128.6 | 5,409,620 | Class A Common Stock |
| Vita Coco Co Inc | Martin F. Roper | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 42,017 | 477,452 | - | 0 | Common Stock | |
| Vita Coco Co Inc | Michael Kirban | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 42,017 | 103,324 | - | 0 | Common Stock | |
| First Horizon Corp | D. Bryan Jordan | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.33 per share. | 04 Mar 2024 | 41,974 | 1,883,725 (0%) | 0% | 14.3 | 601,487 | Common Stock |
| Arlo Tech Inc | Brian Busse | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 41,666 | 83,334 | - | - | Performance Stock Units (PSUs) | |
| Arlo Tech Inc | Brian Busse | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 41,666 | 722,455 (0%) | 0% | - | Common Stock | |
| Iovance Biotherapeutics Inc | Frederick G. Vogt | Interim CEO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 41,662 | 83,338 | - | - | Restricted Stock Units | |
| Iovance Biotherapeutics Inc | Frederick G. Vogt | Interim CEO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 41,662 | 140,800 (0%) | 0% | 0 | Common Stock | |
| TripAdvisor Inc | Seth J. Kalvert | Chief Legal Officer & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 41,620 | 41,620 | - | - | Restricted Stock Units | |
| TripAdvisor Inc | Seth J. Kalvert | Chief Legal Officer & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 41,620 | 41,620 | - | - | Restricted Stock Units (Performance-Based) | |
| B. Riley Fin Inc | Phillip J. Ahn | CFO & Chief Operating Officer | 04 Mar 2024 | 41,543 | 320,795 (1%) | 0% | 0 | Common Stock | ||
| Darling Ingredients Inc | Randall C. Stuewe | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.81 per share. | 04 Mar 2024 | 41,320 | 753,808 (0%) | 0% | 42.8 | 1,768,909 | Common Stock |
| Keurig Dr Pepper | Justin Whitmore | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 41,238 | 41,238 | - | - | Restricted Stock Unit | |
| Keurig Dr Pepper | Roger Frederick Johnson | Chief Supply Chain Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 41,238 | 41,238 | - | - | Restricted Stock Unit | |
| Datadog Inc (Class A) | Olivier Pomel | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 122.73 per share. | 04 Mar 2024 | 41,168 | 381,716 (0%) | 0% | 122.7 | 5,052,722 | Class A Common Stock |
| Sotera Health Co | Jonathan M. Lyons | Sr. Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 41,124 | 118,091 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Amphastar Pharma Inc | William J. Peters | Director, CFO, EVP & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 40,955 | 40,955 | - | - | Employee Stock Option (right to buy) | |
| IonQ Inc | Peter Chapman | Director, PRESIDENT AND CEO | 04 Mar 2024 | 40,937 | 480,685 | - | 0 | Common Stock | ||
| Linde | Matthew J. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 128.38 per share. | 04 Mar 2024 | 40,865 | 133,978 (0%) | 0% | 128.4 | 5,246,249 | Ordinary Shares |
| Linde | Matthew J. White | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 40,865 | 0 | - | - | Stock Option (right to buy) | |
| TFS Fin Corp | Marc A. Stefanski | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 40,700 | 40,700 | - | - | Restricted Stock Units | |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 40,527 | 964,395 | - | - | Stock Option (right to buy) | |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.01 per share. | 04 Mar 2024 | 40,527 | 197,248 | - | 5.0 | 203,040 | Class A Common Stock |
| Fortive | Tamara S. Newcombe | President & CEO of AHS and PT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 40,510 | 40,510 | - | - | Employee Stock Option (Right to Buy) | |
| Taylor Morrison Home Corp | William H. Lyon | Director | Sale of securities on an exchange or to another person at price $ 58.12 per share. | 04 Mar 2024 | 40,122 | 2,623,984 (1%) | 0% | 58.1 | 2,331,891 | Common Stock |
| Immunic Inc | Glenn Whaley | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 40,000 | 0 | - | - | Stock Option | |
| Immunic Inc | Glenn Whaley | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2024 | 40,000 | 0 | - | - | Stock Option | |
| Pennant Group Inc | John J. Gochnour | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| SLR Investment Corp | Michael S. Gross | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 15.08 per share. | 04 Mar 2024 | 40,000 | 3,642,124 (8%) | 0% | 15.1 | 603,200 | Common Stock |
| SLR Investment Corp | Bruce J. Spohler | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 15.08 per share. | 04 Mar 2024 | 40,000 | 3,480,400 (8%) | 0% | 15.1 | 603,200 | Common Stock |
| Airbnb | Aristotle N. Balogh | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 161.00 per share. | 04 Mar 2024 | 40,000 | 146,131 | - | 161 | 6,440,000 | Class A Common Stock |
| Adaptive biotech Corp | Stacy L. Taylor | SVP and General Counsel | 04 Mar 2024 | 39,990 | 179,668 (0%) | 0% | 0 | Common Stock | ||
| MBIA Inc | William C. Fallon | CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.47 per share. | 04 Mar 2024 | 39,659 | 2,810,214 (3%) | 0% | 6.5 | 256,594 | Common Stock |
| Linde | Stephen F. Angel | Director | Sale of securities on an exchange or to another person at price $ 453.66 per share. | 04 Mar 2024 | 39,590 | 374,456 (0%) | 0% | 453.7 | 17,960,399 | Ordinary Shares |
| Caterpillar | D. James Umpleby | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 39,561 | 39,561 | - | - | Employee Stock Options | |
| DENTSPLY Sirona Inc | Richard C. Rosenzweig | SVP, Corp Dev, GC & Secretary | 04 Mar 2024 | 38,900 | 38,900 | - | - | Stock Option (Right to Buy) | ||
| Fortive | James A. Lico | Director, President and CEO | 04 Mar 2024 | 38,620 | 471,414 (0%) | 0% | - | Common Stock | ||
| Darling Ingredients Inc | Randall C. Stuewe | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.81 per share. | 04 Mar 2024 | 37,329 | 734,004 (0%) | 0% | 42.8 | 1,598,054 | Common Stock |
| LanzaTech Global Inc (Class A) | Freya Burton | Chief Sustainability Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.60 per share. | 04 Mar 2024 | 37,268 | 37,268 | - | 1.6 | 59,629 | Common Stock |
| LanzaTech Global Inc (Class A) | Freya Burton | Chief Sustainability Officer | Sale of securities on an exchange or to another person at price $ 3.15 per share. | 04 Mar 2024 | 37,268 | 0 | - | 3.1 | 117,394 | Common Stock |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 128.58 per share. | 04 Mar 2024 | 37,161 | 290,419 (0%) | 0% | 128.6 | 4,778,050 | Class A Common Stock |
| Akamai Tech | F. Thomson Leighton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 36,565 | 36,565 | - | - | TSR Restricted Stock Units | |
| Northern Oil and Gas Inc | Nicholas O’Grady | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 36,007 | 256,832 (0%) | 0% | 0 | Common Stock | |
| Sunopta Inc | Brian W. Kocher | Director, CEO | Purchase of securities on an exchange or from another person at price $ 6.75 per share. | 04 Mar 2024 | 36,000 | 36,000 (0%) | 0% | 6.8 | 243,126 | Common Shares |
| SITE Centers Corp | Conor Fennerty | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 35,705 | 208,471 (0%) | 0% | 0 | Common Shares | |
| Papa Johns International | Robert M. Lynch | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 35,039 | 161,052 (0%) | 0% | 0 | Common Stock | |
| Monster Beverage | Mark J. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 35,000 | 15,000 | - | - | Employee Stock Option (right to buy) | |
| Monster Beverage | Mark J. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.84 per share. | 04 Mar 2024 | 35,000 | 1,402,840 (0%) | 0% | 29.8 | 1,044,400 | Common Stock |
| Pennant Group Inc | Lynette B Walbom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Pennant Group Inc | John J. Gochnour | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 34,568 | 0 | - | - | Stock Option (right to buy) | |
| Pennant Group Inc | John J. Gochnour | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.36 per share. | 04 Mar 2024 | 34,568 | 108,550 (0%) | 0% | 3.4 | 116,148 | Common Stock |
| Lantheus Holdings Inc | Mary Anne Heino | Director | Sale of securities on an exchange or to another person at price $ 64.81 per share. | 04 Mar 2024 | 34,512 | 310,994 (0%) | 0% | 64.8 | 2,236,750 | Common Stock |
| ZipRecruiter Inc (Class A) | Lora Bartolome | SVP, ACCOUNTING & CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 34,500 | 34,500 | - | - | Restricted Stock Units | |
| Hayward Holdings Inc | Susan M. Canning | SVP, CLO, Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 34,111 | 72,932 | - | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.